Key result
Severe TR linked to ~209% higher mortality in HF patients without left-sided valve dysfunction.
Why the study?
The association between different heart failure phenotypes and the adverse effects of tricuspid regurgitation across subtypes of left-sided heart disease remained unclear.
Cohort (n=5,478)
Yes
Hazard Ratio: 3.09 (95% CI 1.87–5.09)
p-value: p=0.005
May refine HF prognosis by left-sided valve status; hypothesis-generating for isolated TR intervention, needs prospective trials.
BACKGROUND: Left-sided heart disease is the leading etiology of tricuspid regurgitation (TR) in heart failure (HF); however, the association between different HF phenotypes and the adverse effects of TR remains unclear. OBJECTIVES: The authors aimed to elucidate the association between TR and outcomes across the subtypes of left-sided heart disease in patients hospitalized for HF. METHODS: We analyzed data from the multicenter West Tokyo Heart Failure registry between January 2006 and December 2021. Moderate or severe mitral or aortic valve disease was defined as left-sided valve dysfunction (LVD). Patients with congenital heart disease, secondary cardiomyopathy, systemic conditions related to HF, or those with incomplete datasets were excluded. Using a multivariable Cox hazard model, the survival effect of TR on mortality in patients with LVD was examined. RESULTS: Overall, 3,040 presented with LVD (median age, 80 years; 45.9% female), and 2,438 had no LVD (median age, 74 years; 27.8% female). The prevalence of moderate and severe TR was 27.6% and 6.5% in patients with LVD and 9.2% and 1.5% in those without LVD, respectively. The adjusted HRs of moderate and severe TR for mortality were 1.25 (95% CI: 1.03-1.52) and 1.72 (95% CI: 1.30-2.29) in those with LVD, respectively, and 2.15 (95% CI: 1.62-2.84) and 3.09 (95% CI: 1.87-5.09) in those without LVD, respectively. Significant interactions between the subtypes were observed (P = 0.005). CONCLUSIONS: TR severity stratified mortality after acute decompensated HF better in patients without LVD than in those with LVD.
No takes yet. Share an insight, caveat, or question.
Kitamura et al. (2025) conducted a cohort in Heart failure (n=5,478). Moderate or severe tricuspid regurgitation vs. No or mild tricuspid regurgitation was evaluated on Mortality (HR 3.09, 95% CI 1.87-5.09, p=0.005). Severe tricuspid regurgitation was associated with higher mortality in heart failure patients without left-sided valve dysfunction (HR 3.09; 95% CI 1.87-5.09) than in those with it (P=0.005).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: